Interaction between oncostatin M, interleukin 1 and prostaglandin E2 in induction of IL-6 expression in human

C D Richards1, A Agro

  • 1Department of Pathology, McMaster University, Hamilton, Ontario, Canada.

Cytokine
|January 1, 1994
PubMed

Insights

Oncostatin M (OM) minimally impacts IL-6 production alone. However, OM synergistically enhances IL-6 expression in fibroblasts when combined with IL-1 alpha or PGE2, impacting inflammatory responses.

Area of Science:

  • Immunology
  • Cell Biology
  • Molecular Biology

Background:

  • Oncostatin M (OM) is a cytokine produced by monocytes, macrophages, and T-cells.
  • Interleukin-6 (IL-6) is a key inflammatory cytokine.
  • Fibroblasts play a role in tissue repair and inflammation.

Purpose of the Study:

  • To investigate the role of Oncostatin M (OM) in regulating Interleukin-6 (IL-6) expression in lung and synovial fibroblasts.
  • To determine if OM synergizes with other inflammatory mediators to enhance IL-6 production.

Main Methods:

  • In vitro cell culture of fibroblasts.
  • Stimulation with Oncostatin M (OM), IL-1 alpha, and Prostaglandin E2 (PGE2).
  • Measurement of IL-6 production via ELISA and mRNA levels via Northern blot.
  • Analysis of gene transcription using a rat IL-6 promoter-luciferase reporter construct.

Main Results:

  • OM alone had minimal effect on IL-6 production.
  • OM synergistically enhanced IL-6 production in combination with IL-1 alpha or PGE2 in a dose-dependent manner.
  • OM, IL-1 alpha, and PGE2 enhanced TIMP-1 mRNA levels, but not stromelysin-1 mRNA.
  • OM stimulation activated transcription, synergistically enhancing IL-1-induced reporter gene expression.

Conclusions:

  • Oncostatin M (OM) plays a significant role in potentiating IL-6 production by fibroblasts, particularly in the presence of other inflammatory mediators like IL-1 alpha and PGE2.
  • The synergistic effect of OM on IL-6 production involves transcriptional activation.
  • These findings highlight the complex interplay of cytokines in regulating fibroblast-mediated inflammatory responses.

Related Concept Videos

The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
Intracellular Signaling Affects Focal Adhesions01:17

Intracellular Signaling Affects Focal Adhesions

Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...